These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4837913)

  • 21. Marihuana-like activity of new synthetic tetrahydrocannabinols.
    Martin BR; Dewey WL; Harris LS; Beckner J
    Pharmacol Biochem Behav; 1975; 3(5):849-53. PubMed ID: 1208625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance to delta9-THC in adult rats with differential delta9-THC exposure when immature or during early adulthood.
    Barnes C; Fried PA
    Psychopharmacologia; 1974 Jan; 34(3):181-90. PubMed ID: 4819974
    [No Abstract]   [Full Text] [Related]  

  • 23. Reduction of predatory aggression of rats following administration of delta-9-tetrahydrocannabinol.
    McDonough JH; Manning FJ; Elsmore TF
    Life Sci I; 1972 Feb; 11(3):103-11. PubMed ID: 4675887
    [No Abstract]   [Full Text] [Related]  

  • 24. Mouse-killing and motor activity: effects of chronic delta9-tetrahydrocannabinol and pilocarpine.
    Miczek KA
    Psychopharmacology (Berl); 1976 May; 47(1):59-64. PubMed ID: 986662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute and chronic effects of beta9-tetrahydrocannabinol on seizures in the gerbil.
    Ten Ham M; Loskota WJ; Lomax P
    Eur J Pharmacol; 1975 Mar; 31(1):148-52. PubMed ID: 1126373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute and subacute interactions between delta9-tetrahydrocannabinol and other drugs in the rat.
    Pryor GT; Husain S; Mitoma C
    Ann N Y Acad Sci; 1976; 281():171-89. PubMed ID: 1071364
    [No Abstract]   [Full Text] [Related]  

  • 27. Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity.
    Anderson PF; Jackson DM; Chesher GB; Malor R
    Psychopharmacologia; 1975 Jul; 43(1):31-6. PubMed ID: 1161992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of (-) 9 -trans-tetrahydrocannabinol and its selectivity in several models of aggressive behavior.
    Dubinsky B; Robichaud RC; Goldberg ME
    Pharmacology; 1973; 9(4):204-16. PubMed ID: 4736761
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacologic interaction between cannabinol and delta9-tetrahydrocannabinol.
    Takahashi RN; Karniol IG
    Psychopharmacologia; 1975; 41(3):277-84. PubMed ID: 168604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of naloxone-induced withdrawal in morphine dependent mice by 1-trans-delta9-tetrahydrocannabinol.
    Bhargava HN
    Eur J Pharmacol; 1976 Mar; 36(1):259-62. PubMed ID: 944134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of acute and chronic pretreatment with delta1-tetrahydrocannabinol on motor impairment by ethanol in the rat.
    Kalant H; LeBlanc AE
    Can J Physiol Pharmacol; 1974 Apr; 52(2):291-7. PubMed ID: 4838189
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of delta9-THC on food and water intake of deprivation experienced rats.
    Gluck JP; Ferraro DP
    Behav Biol; 1974 Jul; 11(3):395-401. PubMed ID: 4413126
    [No Abstract]   [Full Text] [Related]  

  • 33. The psychopharmacology of "cannabis sativa": a review.
    Mills L; Brawley P
    Agents Actions; 1972; 2(5):201-15. PubMed ID: 4629765
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of marihuana (delta9-THC) on behavior patterns and social roles in colonies of CBA mice.
    Ely DL; Henry JP; Jarosz CJ
    Behav Biol; 1975 Mar; 13(3):263-76. PubMed ID: 1168047
    [No Abstract]   [Full Text] [Related]  

  • 35. Increase of serum prolactin in male rats by (minus)-trans-delta9-tetrahydrocannabinol.
    Daley JD; Branda LA; Rosenfeld J; Younglai EV
    J Endocrinol; 1974 Nov; 63(2):415-6. PubMed ID: 4443705
    [No Abstract]   [Full Text] [Related]  

  • 36. Dissociation between behavioral effects and changes in metabolism of cerebral serotonin following 9 -tetrahydrocannabinol.
    Gallager DW; Sanders-Bush E; Sulser F
    Psychopharmacologia; 1972; 26(4):337-45. PubMed ID: 4638199
    [No Abstract]   [Full Text] [Related]  

  • 37. Inactivity of delta9-tetrahydrocannabinol in antidepressant screening tests.
    Sofia RD; Kubena RK; Barry H
    Psychopharmacologia; 1973 Jul; 31(2):121-30. PubMed ID: 4722206
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute and chronic effects on rats of (-) 1 -trans-tetrahydrocannabinol on unlearned motor tasks.
    Potvin RJ; Fried PA
    Psychopharmacologia; 1972; 26(4):369-78. PubMed ID: 4674065
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of repeated doses of l-delta 8-trans-tetrahydrocannabinol on schedule-controlled temporally-spaced responding of rats.
    Frankenheim JM
    Psychopharmacologia; 1974; 38(2):125-44. PubMed ID: 4460069
    [No Abstract]   [Full Text] [Related]  

  • 40. The interaction of delta9-tetrahydrocannabinol with cholinomimetic drugs in an agonist-antagonist paradigm.
    Jones BC; Consroe PF; Laird HE
    Eur J Pharmacol; 1976 Aug; 38(2):253-9. PubMed ID: 954840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.